Pharmafile Logo
Pharmafocus logo
Advanced Search
Facebook image

Facebook dementia app created

April 29, 2014
Medical Communications, Sales and Marketing Alzheimer's, Facebook, app, dementia

Alzheimer’s Research UK has launched a new Facebook app which allows users to see what it is like to suffer …

News
Samsung Incheon plant image

BMS expands Samsung deal

April 29, 2014
Manufacturing and Production BMS, Roche, Samsung, UCSF, biologics, incheon

Bristol-Myers Squibb has expanded its biopharmaceutical manufacturing agreement with South Korea’s Samsung BioLogics. Last year, Bristol-Myers Squibb signed a 10-year …

News
Healthberry image

‘Transformational’ NHS social media tool launches

April 29, 2014
Medical Communications, Sales and Marketing NHS, digital, healthberry, king, social media

London-based startup firm HealthBerry has developed a social media web and mobile application that is set to transform how the …

News
Pfizer image

Pfizer ‘significantly undervalued’ AstraZeneca

April 29, 2014
Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger

AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …

News
joerg_seebeck

PrimeVigilance appoints chief medical officer

April 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance, seebeck

Pharmacovigilance and medical services firm PrimeVigilance has appointed Dr Joerg Seebeck as its chief medical officer.  Seebeck is to head …

Appointment
Humira image

Humira drives AbbVie again

April 28, 2014
Sales and Marketing AbbVie, Abbott, Humira, RA

Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …

News
Haslam image

NICE chair: pharma must show how it prices drugs

April 28, 2014
Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars

The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …

News

Pfizer makes second bid for AstraZeneca

April 28, 2014
Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger

Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …

News
Brazil image

Brazil focus: not just another BRIC in the wall

April 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BRIC, Brazil, emerging markets, market access, rio

Population: 198.7 million (2012) Government: Federal presidential republic Leader: President Dilma Rousseff of the centre-left Workers’ Party Gross Domestic Product: …

Feature
schinazi

reViral hires non-executive director

April 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing reviral, schinazi

Antiviral drug firm reViral has appointed Professor Raymond 
Schinazi as a non-executive director.  Schinazi has had a long and prestigious …

Appointment
gsk image

Mekinist shown green light by CHMP

April 28, 2014
Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib

GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …

News

Novartis reports healthy profit

April 25, 2014
Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly

Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …

News
theresa_stevens

Lupin adds chief corporate development officer

April 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lupin, theresa stevens

Mumbai-based pharma firm Lupin has hired Theresa Stevens to be its chief corporate development officer.   Stevens will be assuming …

Appointment
Channel 4 image

NHS documentary counts cost

April 25, 2014
Medical Communications, Sales and Marketing Channel 4, Drug pricing, NHS, PPRS, vba

The funding issues facing the NHS are to be explored in a new documentary series on Channel 4. Set to …

News
Astrazeneca image

Profits slump at AstraZeneca

April 24, 2014
Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1

AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …

News

Genpact to Acquire Leading Regulatory Affairs Company in Life Sciences

April 24, 2014

News
Press release
bhooshi_de_silva_ppd

PPD hires Bhooshi De Silva as senior VP



April 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PPD, de silva

Contract research organisation Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior VP of corporate development and strategy …

Appointment
sovaldi iamge

Sovaldi performs for Gilead

April 24, 2014
Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …

News
PrimeVigilance Zagreb Office, Croatia

PrimeVigilance Receives Queen’s Award for Enterprise

April 23, 2014

PrimeVigilance Limited (PrimeVigilance), the specialist pharmacovigilance service provider, has been honoured with the Queen’s Award for Enterprise 2014 in the …

News
Press release
Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026